Skip to main navigation Skip to search Skip to main content

Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease from "microclonal" Seborrheic Keratosis

  • University of California San Francisco

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Objectives: We observed keratoses with "clonal" nests present as numerous tiny collections, in which cells in "pagetoid" array are found, a configuration we termed microclonal seborrheic keratosis (MSK). To better distinguish MSK from pagetoid Bowen disease (PBD), we investigated use of immunohistochemical staining. Methods: Biopsy specimens of 26 MSKs, 17 PBDs, and 11 borderline cases were reviewed for histopathology and stained with p53, Ki-67, and p16. Results: High expression of Ki-67 and p16 was observed in 12 (80%) of 15 PBDs and in one (4%) of 23 MSKs. Low expression of p16 and high expression of Ki-67 were observed in 16 (70%) of 23 MSKs and in two (13%) of 15 PBDs. Expression of p16 was elevated in 12 (80%) of 15 PBDs and in three (13%) of 23 MSKs (P <. 0001). Conclusions: We describe a "microclonal" variant of seborrheic keratosis with morphology sometimes challenging to distinguish from PBD. High expression of p16 and Ki-67 or p16 alone favors the diagnosis of PBD over MSK.

Original languageEnglish
Pages (from-to)551-560
Number of pages10
JournalAmerican Journal of Clinical Pathology
Volume151
Issue number6
DOIs
Publication statusPublished - 3 May 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bowen disease
  • Clonal seborrheic keratosis
  • Immunohistochemistry
  • p53

Fingerprint

Dive into the research topics of 'Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease from "microclonal" Seborrheic Keratosis'. Together they form a unique fingerprint.

Cite this